{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T21:58:12Z","timestamp":1785448692658,"version":"3.56.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006034","name":"University of Southern California","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006034","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>\n                      To identify factors associated with adherence to breast cancer (BC) screening among women with a pathogenic or likely pathogenic (P\/LP) variant in a moderate-risk gene,\n                      <jats:italic>ATM<\/jats:italic>\n                      ,\n                      <jats:italic>BARD1<\/jats:italic>\n                      ,\n                      <jats:italic>CHEK2<\/jats:italic>\n                      ,\n                      <jats:italic>RAD51C<\/jats:italic>\n                      , and\n                      <jats:italic>RAD51D<\/jats:italic>\n                      or with empiric lifetime risk\u2009\u2265\u200920%.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We reviewed medical records of women without breast cancer who underwent genetic counseling and testing and were advised to undergo annual breast MRI and mammography. Adherence to screening for up to three years was compared between women with a P\/LP variant in a moderate-risk gene and women with an elevated empiric risk of 20\u201340% by the Tyrer-Cuzick model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The study population included 44 women with P\/LP variants (P\/LP group) and 117 with lifetime BC estimates of 20\u201340% (Empiric group). Within one year, the P\/LP group had significantly higher rates of screening than the Empiric group with 58% vs. 37% obtaining breast MRI and 88% vs. 55% obtaining mammograms. Time-to-event analysis demonstrated the P\/LP group initiated screening significantly sooner than the Empiric group. After adjusting for having family history of BC or personal history of non-BC, the P\/LP group was 3.18 and 7.04 times more likely to obtain breast MRI and mammograms, respectively. Adherence declined in both groups in the second and third year of follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Women with P\/LP variants were more adherent to BC screening than those with empiric risk, underscoring the role that genetic test results may play in screening behavior. Future efforts should focus on understanding the barriers to screening and improving long-term adherence.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10549-026-08020-5","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T07:26:33Z","timestamp":1783668393000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Breast cancer screening adherence after multigene panel testing among women with pathogenic variants in moderate-risk genes or with empirically increased breast cancer risk"],"prefix":"10.1007","volume":"218","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0944-5079","authenticated-orcid":false,"given":"Jacob G.","family":"Comeaux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0620-9345","authenticated-orcid":false,"given":"Charit\u00e9 N.","family":"Ricker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1165-7782","authenticated-orcid":false,"given":"Qi","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Averi","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmeline Y.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca M.","family":"Waggoner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Groshen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caryn","family":"Lerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darcy","family":"Spicer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8658-3507","authenticated-orcid":false,"given":"Julie O.","family":"Culver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"8020_CR1","unstructured":"National Comprehensive Cancer Network. Genetic\/familial high-risk assessment: breast, ovarian, pancreatic, and prostate. Version 3.2026. 2026 [cited 2026 May 29]. Available from: https:\/\/www.nccn.org\/login?ReturnURL=https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/genetics_bopp.pdf."},{"issue":"8","key":"8020_CR2","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1111\/tbj.13967","volume":"26","author":"T Sciaraffa","year":"2020","unstructured":"Sciaraffa T, Guido B, Khan SA, Kulkarni S (2020) Breast cancer risk assessment and management programs: A practical guide. Breast J 26(8):1556\u20131564","journal-title":"Breast J"},{"key":"8020_CR3","unstructured":"National Comprehensive Cancer Network. Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic. Version 2.2021. 2021 [cited 2020 Dec 4]. Available from: https:\/\/www.nccn.org\/login?ReturnURL=https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/genetics_bopp.pdf."},{"key":"8020_CR4","unstructured":"American Cancer Society. Breast cancer statistics: how common is breast cancer? [Internet]. 2026 [cited 2026 May 29]. Available from: https:\/\/www.cancer.org\/cancer\/types\/breast-cancer\/about\/how-common-is-breast-cancer.html."},{"issue":"7","key":"8020_CR5","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/sim.1668","volume":"23","author":"J Tyrer","year":"2004","unstructured":"Tyrer J, Duffy SW, Cuzick J (2004) A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 23(7):1111\u20131130","journal-title":"Stat Med"},{"issue":"13","key":"8020_CR6","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1016\/j.ejca.2007.06.007","volume":"43","author":"SJ Lord","year":"2007","unstructured":"Lord SJ, Lei W, Craft P, Cawson JN, Morris I, Walleser S, Griffiths A, Parker S, Houssami N (2007) A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer. Eur J Cancer 43(13):1905\u20131917","journal-title":"Eur J Cancer"},{"key":"8020_CR7","unstructured":"National Comprehensive Cancer Network. Breast cancer screening and diagnosis. Version 1.2026. 2026 [cited 2026 May 29]. Available from: https:\/\/www.nccn.org\/login?ReturnURL=https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast-screening.pdf."},{"issue":"2","key":"8020_CR8","first-page":"75","volume":"57","author":"D Saslow","year":"2007","unstructured":"Saslow D, Boetes C, Burke W, Harms S, Leach MO, Lehman CD, Morris E, Pisano E, Schnall M, Sener S et al (2007) American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57(2):75\u201389","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"8020_CR9","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1001\/jamaoncol.2021.6204","volume":"8","author":"KP Lowry","year":"2022","unstructured":"Lowry KP, Geuzinge HA, Stout NK, Alagoz O, Hampton J, Kerlikowske K, de Koning HJ, Miglioretti DL, van Ravesteyn NT, Schechter C et al (2022) Breast Cancer Screening Strategies for Women With ATM, CHEK2, and PALB2 Pathogenic Variants: A Comparative Modeling Analysis. JAMA Oncol 8(4):587\u2013596","journal-title":"JAMA Oncol"},{"issue":"6","key":"8020_CR10","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1067\/j.cpradiol.2022.04.006","volume":"51","author":"NJ Patel","year":"2022","unstructured":"Patel NJ, Mussallem DM (2022) Maimone St: Identifying and Managing Patients with Elevated Breast Cancer Risk Presenting for Screening Mammography. Curr Probl Diagn Radiol 51(6):838\u2013841","journal-title":"Curr Probl Diagn Radiol"},{"issue":"1","key":"8020_CR11","doi-asserted-by":"publisher","first-page":"e2454447","DOI":"10.1001\/jamanetworkopen.2024.54447","volume":"8","author":"LA Naghi","year":"2025","unstructured":"Naghi LA, Culver JO, Ricker C, Sturgeon D, Kingham K, Hodan R, Chun NM, Kidd J, Bonner J, Hong C et al (2025) Breast Cancer MRI Screening of Patients After Multiplex Gene Panel Testing. JAMA Netw Open 8(1):e2454447","journal-title":"JAMA Netw Open"},{"issue":"2","key":"8020_CR12","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s10549-020-05699-y","volume":"182","author":"D Cragun","year":"2020","unstructured":"Cragun D, Weidner A, Tezak A, Clouse K, Pal T (2020) Cancer risk management among female BRCA1\/2, PALB2, CHEK2, and ATM carriers. Breast Cancer Res Treat 182(2):421\u2013428","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"8020_CR13","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s10549-023-07007-w","volume":"201","author":"S Knerr","year":"2023","unstructured":"Knerr S, Guo B, Wernli KJ, Mittendorf KF, Feigelson HS, Gilmore MJ, Jarvik GP, Kauffman TL, Keast E, Liles EG et al (2023) Longitudinal adherence to breast cancer surveillance following cancer genetic testing in an integrated health care system. Breast Cancer Res Treat 201(3):461\u2013470","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"8020_CR14","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/cncr.32572","volume":"126","author":"V Vysotskaia","year":"2020","unstructured":"Vysotskaia V, Kaseniit KE, Bucheit L, Ready K, Price K, Johansen Taber K (2020) Clinical utility of hereditary cancer panel testing: Impact of PALB2, ATM, CHEK2, NBN, BRIP1, RAD51C, and RAD51D results on patient management and adherence to provider recommendations. Cancer 126(3):549\u2013558","journal-title":"Cancer"},{"issue":"5","key":"8020_CR15","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s10897-018-0238-4","volume":"27","author":"D Braun","year":"2018","unstructured":"Braun D, Yang J, Griffin M, Parmigiani G, Hughes KS (2018) A Clinical Decision Support Tool to Predict Cancer Risk for Commonly Tested Cancer-Related Germline Mutations. J Genet Couns 27(5):1187\u20131199","journal-title":"J Genet Couns"},{"issue":"8","key":"8020_CR16","first-page":"1708","volume":"21","author":"A Lee","year":"2019","unstructured":"Lee A, Mavaddat N, Wilcox AN, Cunningham AP, Carver T, Hartley S, Babb de Villiers C, Izquierdo A, Simard J, Schmidt MK et al (2019) BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors. Genet Sci 21(8):1708\u20131718","journal-title":"Genet Sci"},{"key":"8020_CR17","unstructured":"R Core Team. R: A language and environment for statistical computing [software]. Version 4.5.0. Vienna, Austria: R Foundation for Statistical Computing; 2025."},{"issue":"3","key":"8020_CR18","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/tbj.12396","volume":"21","author":"S Ehsani","year":"2015","unstructured":"Ehsani S, Strigel RM, Pettke E, Wilke L, Tevaarwerk AJ, DeMartini WB, Wisinski KB (2015) Screening magnetic resonance imaging recommendations and outcomes in patients at high risk for breast cancer. Breast J 21(3):246\u2013253","journal-title":"Breast J"},{"key":"8020_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1472-6963-9-9","volume":"9","author":"SG Moore","year":"2009","unstructured":"Moore SG, Shenoy PJ, Fanucchi L, Tumeh JW, Flowers CR (2009) Cost-effectiveness of MRI compared to mammography for breast cancer screening in a high risk population. BMC Health Serv Res 9:9","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"8020_CR20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s10549-024-07471-y","volume":"209","author":"CC Conley","year":"2025","unstructured":"Conley CC, Anderson A, Rodriguez JD, Kang H, Taylor EP, Luck C, Rosas Torres J, Cheraghi N, Newton N, Niell BL et al (2025) Barriers and facilitators to breast cancer screening among high-risk women: a qualitative study. Breast Cancer Res Treat 209(1):61\u201371","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"8020_CR21","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.amjsurg.2019.02.021","volume":"217","author":"WS Do","year":"2019","unstructured":"Do WS, Weiss JB, McGregor HF, Forte DM, Sheldon RR, Sohn VY (2019) Poor compliance despite equal access: Military experience with screening breast MRI in high risk women. Am J Surg 217(5):843\u2013847","journal-title":"Am J Surg"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-026-08020-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-026-08020-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-026-08020-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T21:04:11Z","timestamp":1785445451000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-026-08020-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["8020"],"URL":"https:\/\/doi.org\/10.1007\/s10549-026-08020-5","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"19 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Board of the University of Southern California.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"6"}}